Keryx Biopharmaceuticals says that it does not believe that it will need to carry out more tests so that its kidney drug Zerenex (ferric citrate) will be approved in Europe. This was reported on several news sites.
The drug is used to treat high phosphate levels (hyperphosphatemia) in patients with chronic kidney disease as well as those on dialysis. The drug is already licensed in many other
Subscribe to:
Post Comments (Atom)
Post a Comment